SEC Form 4 · accession 0001104659-17-051049
PRA Health Sciences, Inc. · PRAH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Linda Baddour
Officer — Executive VP & CFO
Period of report
Aug 8, 2017
Accepted (ET)
Aug 10, 2017 · 4:08 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001613859
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Aug 8, 2017 | M | 100,000 | $11.73 | A | 100,000 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $11.73 | Aug 8, 2017 | M | 47,035 | D | — | Dec 20, 2023 | Common Stock | 47,035 | 79,305 | D |
| Stock Option (Right to Buy)F2 | $11.73 | Aug 8, 2017 | M | 52,965 | D | — | Dec 20, 2023 | Common Stock | 52,965 | 145,295 | D |
Explanation of responses
- F17,383 of the options vested on September 23, 2015; 39,652 of the options vested on September 23, 2016. The remaining options will vest in equal installments on September 23, 2017 and September 23, 2018.
- F2The options vested on March 2, 2016 upon satisfaction of certain performance criteria.